Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis

J Thromb Thrombolysis. 2021 Jul;52(1):124-129. doi: 10.1007/s11239-021-02436-0. Epub 2021 Apr 4.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Aspirin / therapeutic use*
  • COVID-19 / mortality*
  • COVID-19 Drug Treatment
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin